Doxorubicin/Iodoacetamide PEG reagent, N-(Iodoacetamido)-doxorubicin, Purity 95%

Cat. No.: X24-03-YW0625

Doxorubicin/Iodoacetamide PEG reagent, N-(Iodoacetamido)-doxorubicin, Purity 95%

Synonym: 114390-30-6; N-(Iodoacetamido)-Doxorubicin; N-iodoacetyladriamycin

  • CAS Number: 114390-30-6
  • PubChem CID: 129737886
Size
25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
N-(Iodoacetamido)-doxorubicin is a modified doxorubicin derivative featuring an iodoacetamido moiety. This reactive iodoacetamido group enables covalent conjugation with thiol and amine groups, while the doxorubicin core retains its potent anthracycline-based antineoplastic activity, commonly used in cancer research.
Molecular Weight
711.5
Molecular Formula
C29H30INO12
Functional Group 1
Doxorubicin
Functional Group 2
Iodoacetamide
Reactive Group 1
Amine
Reactive Group 2
Thiol
Form
Solid
Purity
95%
Solubility
DMSO, DMF
Identity
Confirmed by NMR.
Applications
N-(Iodoacetamido)-doxorubicin is employed in targeted drug delivery, antibody-drug conjugates (ADCs), and cancer research. Its iodoacetamido group allows for site-specific conjugation with biomolecules, enhancing targeted therapeutic applications and facilitating the development of novel chemotherapeutic agents.
Storage
Store at -20°C.
For Research Use Only. Not For Clinical Use.

Unleash the full potential of glycochemistry research with CD BioGlyco, the top CRO company committed to advancing the understanding of glycobiology through tailored solutions and exceptional expertise.

Copyright © CD BioGlyco. All Rights Reserved.
Top